Education
About Us
Working with TipRanks
Follow Us
StageZero Life Sciences Ltd (TSE:SZLS)
TSX:SZLS
Total Valuation
StageZero Life Sciences Ltd has a market cap or net worth of C$4.94M. The enterprise value is .
Market CapC$4.94M
Enterprise Value
Share Statistics
StageZero Life Sciences Ltd has 123.55M shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding123.55M
Owned by Insiders
Owned by Instutions0.01%
Financial Efficiency
StageZero Life Sciences Ltd’s return on equity (ROE) is ― and return on invested capital (ROIC) is ―.
Return on Equity (ROE)―
Return on Assets (ROA)―
Return on Invested Capital (ROIC)―
Return on Capital Employed (ROCE)―
Revenue Per EmployeeC$35,291.675
Profits Per Employee-C$35,877.125
Employee Count40
Asset Turnover―
Inventory Turnover―
Valuation Ratios
The current PE Ratio of StageZero Life Sciences Ltd is ―. StageZero Life Sciences Ltd’s PEG ratio is ―.
PE Ratio―
PS Ratio―
PB Ratio―
Price to Fair Value―
Price to FCF―
Price to Operating Cash Flow―
PEG Ratio―
Income Statement
In the last 12 months, StageZero Life Sciences Ltd had revenue of C$1.41M and earned -C$1.44M in profits. Earnings per share was -C$0.01.
RevenueC$1.41M
Gross ProfitC$238.76K
Operating Income-C$1.34M
Pretax Income-C$1.44M
Net Income-C$1.44M
EBITDA-1.20M
Earnings Per Share (EPS)-0.01
Cash Flow
In the last 12 months, operating cash flow was -C$145.60K and capital expenditures C$0.00, giving a free cash flow of -C$145.60K billion.
Operating Cash Flow-C$145.60K
Free Cash Flow-C$145.60K
Free Cash Flow per Share>-C$0.01
Dividends & Yields
StageZero Life Sciences Ltd pays an annual dividend of , resulting in a dividend yield of
Dividend Per Share
Dividend Yield
Payout Ratio
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.38
52-Week Price Change0.00%
50-Day Moving Average0.04
200-Day Moving Average0.04
Relative Strength Index (RSI)88.09
Average Volume (3m)0.00
Important Dates
StageZero Life Sciences Ltd upcoming earnings date is May 20, 2025, TBA.
Last Earnings DateNov 12, 2024
Next Earnings DateMay 20, 2025
Ex-Dividend Date―
Financial Position
StageZero Life Sciences Ltd as a current ratio of ―, with Debt / Equity ratio of ―
Current Ratio―
Quick Ratio―
Debt to Market Cap―
Net Debt to EBITDA―
Interest Coverage Ratio―
Taxes
In the past 12 months, StageZero Life Sciences Ltd has paid C$0.00 in taxes.
Income TaxC$0.00
Effective Tax Rate―
Enterprise Valuation
StageZero Life Sciences Ltd EV to EBITDA ratio is ―, with an EV/FCF ratio of ―.
EV to Sales―
EV to EBITDA―
EV to Free Cash Flow―
EV to Operating Cash Flow―
Balance Sheet
StageZero Life Sciences Ltd has C$15.03K in cash and marketable securities with C$2.13M in debt, giving a net cash position of C$2.12M billion.
Cash & Marketable SecuritiesC$15.03K
Total DebtC$2.13M
Net CashC$2.12M
Net Cash Per ShareC$0.02
Tangible Book Value Per Share―
Margins
Gross margin is ―, with operating margin of ―, and net profit margin of ―.
Gross Margin―
Operating Margin―
Pretax Margin―
Net Profit Margin―
EBITDA Margin―
EBIT Margin―
Analyst Forecast
The average price target for StageZero Life Sciences Ltd is , which is 11.43% higher than the current price. The consensus rating is
Price Target
Price Target Upside
Analyst Consensus
Analyst Count0
Revenue Growth Forecast
EPS Growth Forecast